Jove
Visualize
Contact Us

Related Experiment Videos

Neonatal alloimmune thrombocytopenia.

T S Kickler1

  • 1Johns Hopkins Hospital Blood Bank, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Clinics in Laboratory Medicine
|September 1, 1992
PubMed
Summary

Neonatal alloimmune thrombocytopenia (NAIT) occurs when maternal antibodies cross the placenta, targeting fetal platelets. Early diagnosis using serologic techniques is crucial for timely prenatal and postnatal treatment to prevent bleeding complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel diagnostic algorithm for heparin-induced thrombocytopenia.

International journal of laboratory hematology·2018
Same author

Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia.

Clinical and laboratory haematology·2004
Same author

Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Bra).

Immunohematology·2004
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Neonatal Medicine
  • Hematology

Background:

  • Neonatal alloimmune thrombocytopenia (NAIT) is an immune condition in newborns.
  • It results from maternal antibodies crossing the placenta and targeting fetal platelet-specific antigens.
  • Potential complications include severe bleeding events in neonates.

Purpose of the Study:

  • To highlight the importance of accurate diagnosis in managing NAIT.
  • To emphasize the necessity of prompt therapeutic interventions.
  • To underscore the role of serologic techniques in guiding treatment decisions.

Main Methods:

  • Review of existing literature on NAIT pathogenesis and diagnosis.
  • Analysis of serologic techniques for identifying anti-platelet antibodies.
  • Discussion of therapeutic strategies for NAIT management.

Main Results:

  • Maternal antibodies against fetal platelet-specific antigens are the primary cause of NAIT.
  • Serologic testing enables precise identification of causative antibodies.
  • Prompt diagnosis facilitates effective prenatal and postnatal treatment.

Conclusions:

  • Accurate serologic diagnosis is essential for effective management of NAIT.
  • Timely therapeutic interventions, guided by diagnosis, can prevent severe neonatal bleeding.
  • Understanding the immunologic basis of NAIT is key to improving neonatal outcomes.

Related Experiment Videos